Advanced Renal Cell Carcinoma, With Failure or Unsuitable on Prior Interferon-alpha or Interleukin-2 Based Therapy
Clinical trial NCT01195649 · TERMINATED
Trial details
- NCT number
- NCT01195649
- Sponsor
- Bayer
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2010-12-13
- Primary completion
- 2012-06-08
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.